RAIR Health Limited today announces it has joined the PathLAKE consortium as an Associate Member, supporting its work in image-based AI and computational pathology. RAIR’s expertise is in the application of AI-driven biomedical knowledge systems and feature extraction from medical images to derive insights from clinical data. By joining the PathLAKE consortium RAIR furthers its strategy of helping healthcare organisations apply AI to real-world data, and to improve patient outcomes.

Led by University Hospitals Coventry and Warwickshire (UHCW) NHS Trust, the PathLAKE consortium comprises some of the UK’s leading digital and computational innovators from the NHS, academia, and industry. By digitizing five major NHS pathology labs and forming a computational hub, it has driven AI innovation and created the world’s largest repository of annotated, digital, whole-slide images.

Also Read: 5 Business Industries Positively Impacted by AI Disruption

RAIR aims to help generate new insights using OCULAIR™, its state-of-the-art biomedical knowledge system launched in May 2021. OCULAIR™ gives medical researchers the ability to use AI to discover, interact and draw insights from a vast store of structured and unstructured life science data. RAIR has also built a clinical image processing workflow which, together with algorithms written for OCULAIR™, can assist researchers in cellular pathology and related image-based clinical fields.

Speaking about the consortium, Steve Cox CEO of RAIR, said:

“We are delighted to join the PathLAKE consortium and to help members build the largest, most advanced resource for digital pathology. We recognise the challenge of bringing complex datasets and images together to drive clinical research, but we are confident that, working together with consortium members, we can achieve this ambition”.

For more such updates follow us on Google News Enterprisetalk News.